Last reviewed · How we verify

VAC BNO 1095 film coated tablets — Competitive Intelligence Brief

VAC BNO 1095 film coated tablets (VAC BNO 1095 film coated tablets) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal medicinal product. Area: Immunology / Respiratory / Inflammation.

phase 3 Herbal medicinal product Immunology / Respiratory / Inflammation Small molecule Live · refreshed every 30 min

Target snapshot

VAC BNO 1095 film coated tablets (VAC BNO 1095 film coated tablets) — Bionorica SE. VAC BNO 1095 is a herbal film-coated tablet formulation that modulates immune and inflammatory responses through its botanical active constituents.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
VAC BNO 1095 film coated tablets TARGET VAC BNO 1095 film coated tablets Bionorica SE phase 3 Herbal medicinal product

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal medicinal product class)

  1. Bionorica SE · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). VAC BNO 1095 film coated tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/vac-bno-1095-film-coated-tablets. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: